What does CLINICANALYTICA do?

CLINICANALYTICA is a healthcare practice in Gent. Private Limited, started on 24 June 2022, 1 establishment.

What is the address of CLINICANALYTICA?

The registered office of CLINICANALYTICA is located at Steenhouwersstraat 72, 9050 Gent.

Is CLINICANALYTICA still active?

Yes. According to the CBE (2 November 2026) CLINICANALYTICA is active, legal situation “Normale toestand”, started on 24 June 2022.

Is CLINICANALYTICA registered on Peppol?

Yes, CLINICANALYTICA is registered on the Peppol network with ID 0208:0787651183.

What is the enterprise number of CLINICANALYTICA?

The enterprise number of CLINICANALYTICA is BE0787651183.

When was CLINICANALYTICA founded?

CLINICANALYTICA was founded on 24 June 2022.

Who are the directors of CLINICANALYTICA?

According to the 2025 annual accounts, the directors of CLINICANALYTICA are: Frederick Verbeke.

Is CLINICANALYTICA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 June 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did CLINICANALYTICA make in 2025?

CLINICANALYTICA posted a profit after taxes of € 201,575 in financial year 2025.

What is the revenue of CLINICANALYTICA?

As a small company, CLINICANALYTICA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 272,272.

CLINICANALYTICA (Private Limited) - Gent - BE0787651183

Dossier CLINICANALYTICA, printed on 3 November 2026 from databakkes.be/en/0787651183/clinicanalytica. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 9 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

CLINICANALYTICA from Gent, company number BE0787651183, closed financial year 2025 with a result of € 201,575 after tax. For that financial year CLINICANALYTICA recorded a gross margin of € 272,272 and equity of € 44,575. Compared with financial year 2024, the result moved from € 143,296 to € 201,575. Profitable, and profit is growing. The buffer shrank hard: equity is 83 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Shrank hard

€ 44,575

▼ 83% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 201,575

▲ 41% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 7,953

▼ 90% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 425,372 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 9,104

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 18,333

▲ 22% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 618

▼ 85% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 18,171 Gross margin 2022: € 18,171 First fiscal year in the series	€ 145,009 Gross margin 2023: € 145,009 ▲ € 126,838 vs 2022 (€ 18,171) Favourable step	€ 188,748 Gross margin 2024: € 188,748 ▲ 30% vs 2023 (€ 145,009) Favourable step	€ 272,272 Gross margin 2025: € 272,272 ▲ 44% vs 2024 (€ 188,748) Favourable step	▲ 44%
Profit after taxes	€ 13,422 Profit after taxes 2022: € 13,422 First fiscal year in the series	€ 111,120 Profit after taxes 2023: € 111,120 ▲ € 97,699 vs 2022 (€ 13,422) Favourable step	€ 143,296 Profit after taxes 2024: € 143,296 ▲ 29% vs 2023 (€ 111,120) Favourable step	€ 201,575 Profit after taxes 2025: € 201,575 ▲ 41% vs 2024 (€ 143,296) Favourable step	▲ 41%
Equity	€ 15,622 Equity 2022: € 15,622 First fiscal year in the series	€ 125,909 Equity 2023: € 125,909 ▲ € 110,287 vs 2022 (€ 15,622) Favourable step	€ 268,372 Equity 2024: € 268,372 ▲ 113% vs 2023 (€ 125,909) Favourable step	€ 44,575 Equity 2025: € 44,575 ▼ 83% vs 2024 (€ 268,372) Unfavourable step	▼ 83%
Total debts	€ 13,340 Total debts 2022: € 13,340 First fiscal year in the series	€ 31,418 Total debts 2023: € 31,418 ▲ 136% vs 2022 (€ 13,340) Unfavourable step	€ 20,209 Total debts 2024: € 20,209 ▼ 36% vs 2023 (€ 31,418) Favourable step	€ 166,455 Total debts 2025: € 166,455 ▲ € 146,246 vs 2024 (€ 20,209) Unfavourable step	▲ € 146,246
Cash	€ 8,396 Cash 2022: € 8,396 First fiscal year in the series	€ 31,228 Cash 2023: € 31,228 ▲ 272% vs 2022 (€ 8,396) Favourable step	€ 80,497 Cash 2024: € 80,497 ▲ 158% vs 2023 (€ 31,228) Favourable step	€ 7,953 Cash 2025: € 7,953 ▼ 90% vs 2024 (€ 80,497) Unfavourable step	▼ 90%
Land & buildings	-	-	€ 31,650 Land & buildings 2024: € 31,650 First fiscal year in the series	€ 27,783 Land & buildings 2025: € 27,783 ▼ 12% vs 2024 (€ 31,650) Unchanged	▼ 12%
Retained profit	€ 12,622 Retained profit 2022: € 12,622 First fiscal year in the series	€ 122,909 Retained profit 2023: € 122,909 ▲ € 110,287 vs 2022 (€ 12,622) Favourable step	€ 265,372 Retained profit 2024: € 265,372 ▲ 116% vs 2023 (€ 122,909) Favourable step	€ 41,575 Retained profit 2025: € 41,575 ▼ 84% vs 2024 (€ 265,372) Unfavourable step	▼ 84%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 833 Dividend 2023: € 833 ▲ 4% vs 2022 (€ 800) Unchanged	€ 833 Dividend 2024: € 833 Unchanged (€ 833) Unchanged	€ 425,372 Dividend 2025: € 425,372 ▲ € 424,539 vs 2024 (€ 833) Unchanged	▲ € 424,539
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 15,000 Bank debt 2024: € 15,000 Unchanged (€ 0) Unfavourable step	€ 18,333 Bank debt 2025: € 18,333 ▲ 22% vs 2024 (€ 15,000) Unfavourable step	▲ 22%
Balance sheet total	€ 28,961 Balance sheet total 2022: € 28,961 First fiscal year in the series	€ 157,327 Balance sheet total 2023: € 157,327 ▲ € 128,366 vs 2022 (€ 28,961) Unchanged	€ 288,580 Balance sheet total 2024: € 288,580 ▲ 83% vs 2023 (€ 157,327) Unchanged	€ 211,030 Balance sheet total 2025: € 211,030 ▼ 27% vs 2024 (€ 288,580) Unchanged	▼ 27%

Key figures of CLINICANALYTICA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CLINICANALYTICA?

What happened at CLINICANALYTICA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: profit of € 201,575 (▲ 41% vs 2024). Source: NBB ↗
Jun 28, 2022 Incorporation, published in the Gazette. Source: Staatsblad ↗
Jun 24, 2022 New establishment in Gent. KBO
2022 Frederick Verbeke became a director. NBB

In short

From € 13,422 profit in 2022 to € 201,575 profit in 2025.

Paid € 137,985 in corporate taxes since 2022.

Best year ever: 2025, with € 201,575 profit.

Paid out € 427,838 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Frederick Verbeke

CLINICANALYTICA

Behind CLINICANALYTICA is Frederick Verbeke.

Directors

According to the 2025 annual accounts

Frederick Verbeke

Director

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Steenhouwersstraat 72

9050 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

28 June 2022 Source: Deed ↗

VERBEKE Frederick Yvan Lucien(oprichter) 100%

Details

Company number

0787.651.183

VAT number

BE 0787.651.183

Registered office

Steenhouwersstraat 72, 9050 Gent

Names & denominations

CLINICANALYTICA

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

24 June 2022

Peppol

Active · Active since 19 Nov 2025

Activities · NACE

Activiteiten van medische beeldvorming en medische laboratoria

Activiteiten van medische laboratoria

Speur- en ontwikkelingswerk op biotechnologisch gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

View on CBE Public ↗ Annual accounts (NBB) ↗

CLINICANALYTICA

Warning lights

Financials

What happened to CLINICANALYTICA?

Management

Directors

Establishments

Establishment units

Shareholders according to the Official Gazette deeds

Details

Frequently asked questions